TAP Blocks With Ropivacaine Continuous Infusion Catheters vs Single Dose Liposomal Bupivicaine After Kidney Transplant

Description

This study is a comparison of the analgesic efficacy of transversus abdominis plane (TAP) blocks with ropivacaine bolus plus continuous ropivacaine infusion via catheters versus single shot TAP blocks with liposomal bupivacaine.

Conditions

Transplant;Failure,Kidney, Pain, Postoperative

Talk to us

Study Overview

On this page

Study Details

Study overview

This study is a comparison of the analgesic efficacy of transversus abdominis plane (TAP) blocks with ropivacaine bolus plus continuous ropivacaine infusion via catheters versus single shot TAP blocks with liposomal bupivacaine.

Transversus Abdominis Plane (TAP) Blocks With Ropivacaine Continuous Infusion Catheters vs Single Dose Liposomal Bupivicaine: A Prospective Randomized Control Trial for Pain Control After Renal Transplant Surgery

TAP Blocks With Ropivacaine Continuous Infusion Catheters vs Single Dose Liposomal Bupivicaine After Kidney Transplant

Condition
Transplant;Failure,Kidney
Intervention / Treatment

-

Contacts and Locations

Sacramento

University of California Davis, Sacramento, California, United States, 95817

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patients ages 18 years or older
  • * Renal Transplant Recipients
  • * Patients less than 18 years of age
  • * Pregnant Women
  • * Prisoners
  • * Opioid Tolerant Patients taking more than 30 mg/day of oral morphine equivalent analgesia
  • * Patients on Systemic anti coagulation
  • * Patients unable to provide consent
  • * Hypersensitivity to amide-type local anesthetic or any component of the drug formula

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

University of California, Davis,

Study Record Dates

2025-07-01